On this page
Effective treatments for Covid-19 could help change the course of this pandemic – from saving lives to reducing the pressure on healthcare systems. A collective global effort is needed to fund, research, develop and bring effective treatments to people, as soon as possible.
When will we have effective treatments?
Research into treatments for Covid-19 is moving at an incredible speed – with thousands of studies in progress and more than 400 potential therapies being explored.
Large randomised clinical trials, such as the World Health Organization’s Solidarity clinical trial and the UK’s RECOVERY trial, are essential for learning which treatments are safe and effective.
Most of the current research focuses on repurposed drugs – if shown to be effective, these could be rapidly rolled out across the world. Among the new drugs that are being developed specifically for Covid-19, monoclonal antibodies are some of the most promising ones.
For more than 30 years, monoclonal antibodies have transformed the way we treat many diseases. Researchers think they are also one of the most promising treatments for Covid-19. Here's why.
From repurposed drugs to new therapies – researchers are working at incredible speed to find the best ways to treat Covid-19 patients.
Effective treatments, that are accessible to everyone who needs them, have to be part of the solution to the coronavirus pandemic – here's why.
How we’re supporting research
We launched the COVID-19 Therapeutics Accelerator together with the Bill & Melinda Gates Foundation and Mastercard.
This is a large-scale collaboration to research, develop and bring effective treatments to market quickly and accessibly. The studies funded so far include evaluating approved drugs and creating platforms for exploring new potential treatments.
Find out how to apply for funding from or donate to the Therapeutics Accelerator.
Treatments for everyone
Any – and all – effective treatments for Covid-19 must be available to everyone around the world. Those who need them most, not those who can afford to buy them, should have access first.
The ACT Accelerator, a global collaboration of governments and international organisations, was set up to support the development, production and equitable access to all tools that will help protect people against Covid-19.
Treatments will take the fear and helplessness out of coronavirus – here’s how businesses can help find them
Science will show us the way out of the COVID-19 pandemic. And businesses and philanthropy can play a major role by stepping up to fund coronavirus treatments, as well as vaccines and tests.
Covid-19 is exacerbating existing health, economic and social inequalities in the US and across the world. Claude Lopez explains why investing in coronavirus treatment research and development is an imperative for business leaders and philanthropists.